Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses. Shareholders should contact the...
Covered in this story
Analyst targets on Humana
- Raymond James: at $434 · target $520 by Nov 2027 · Outperform via Investing.com
- Baird: at $432 · target $596 by Oct 2027 · Outperform via Investing.com
- Barclays: at $398 · target $515 by Sep 2027 · Overweight via 247wallst.com
“At” is the closing price nearest the day the target was reported, the price we score it from; it is not an earlier target. Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $HUM yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Humana →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.